129 related articles for article (PubMed ID: 36807167)
1. [Interstitial Lung Disease after OK-432 Pleurodesis for Malignant Pleural Effusion in Breast Cancer-A Case Report].
Kobayashi N; Tono Y; Tsunoda A; Oka H; Saito K; Yamashita Y; Mizuno T; Tawara I
Gan To Kagaku Ryoho; 2023 Feb; 50(2):183-186. PubMed ID: 36807167
[TBL] [Abstract][Full Text] [Related]
2. Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion.
Yokoe N; Katsuda E; Kosaka K; Hamanaka R; Matsubara A; Nishimura M; Tanaka H; Asai N; Takahashi A; Kawamura T; Ishiguchi T; Yamaguchi E; Kubo A
Intern Med; 2017; 56(14):1791-1797. PubMed ID: 28717073
[TBL] [Abstract][Full Text] [Related]
3. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial.
Luh KT; Yang PC; Kuo SH; Chang DB; Yu CJ; Lee LN
Cancer; 1992 Feb; 69(3):674-9. PubMed ID: 1309678
[TBL] [Abstract][Full Text] [Related]
4. [A case of anaphylactic reaction after pleurodesis with OK-432].
Kashiwada T; Shimizu H; Arai Y; Horie Y; Mizoo A; Takizawa S
Nihon Kokyuki Gakkai Zasshi; 2009 Oct; 47(10):965-8. PubMed ID: 19882924
[TBL] [Abstract][Full Text] [Related]
5. A propensity score-matched comparison of the efficacies of OK-432 and talc slurry for pleurodesis for malignant pleural effusion induced by lung adenocarcinoma.
Nohara K; Takada K; Kojima E; Ninomiya K; Miyamatsu S; Shimizu T; Sakurai T; Mizuno T; Yamashita Y
Respir Investig; 2016 Sep; 54(5):341-6. PubMed ID: 27566382
[TBL] [Abstract][Full Text] [Related]
6. [Two patients of recurrent breast cancer with carcinomatous pleurisy well controlled pleural effusion].
Hojo S; Maeura Y; Fukunaga H; Yoshioka S; Ota H; Endo W; Yamazaki K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1795-7. PubMed ID: 16315944
[TBL] [Abstract][Full Text] [Related]
7. Pleurodesis using OK-432 for persistent pleural effusion after cardiac surgery in the neonatal period or early infancy.
Nakata T; Tachi M; Yasuda K; Nakashima S; Ikeda T; Minatoya K; Oda T
Asian Cardiovasc Thorac Ann; 2024 Mar; 32(2-3):83-90. PubMed ID: 38073052
[TBL] [Abstract][Full Text] [Related]
8. Old age and underlying interstitial abnormalities are risk factors for development of ARDS after pleurodesis using limited amount of large particle size talc.
Shinno Y; Kage H; Chino H; Inaba A; Arakawa S; Noguchi S; Amano Y; Yamauchi Y; Tanaka G; Nagase T
Respirology; 2018 Jan; 23(1):55-59. PubMed ID: 28980363
[TBL] [Abstract][Full Text] [Related]
9. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions.
Kishi K; Homma S; Sakamoto S; Kawabata M; Tsuboi E; Nakata K; Yoshimura K
Eur Respir J; 2004 Aug; 24(2):263-6. PubMed ID: 15332395
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer: a new risk model for success from an analysis of 75 cases.
Matsubara N; Itoh K; Mukai H; Nagai S
Int J Clin Oncol; 2012 Oct; 17(5):470-6. PubMed ID: 21979749
[TBL] [Abstract][Full Text] [Related]
11. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.
Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T
Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251
[TBL] [Abstract][Full Text] [Related]
12. [Successful treatment of pleurodesis for seemingly intractable pleural effusion in pleural amyloidosis with rheumatoid arthritis].
Masunaga A; Takeda N; Akaike K; Tsumori K; Goto E; Ichiyasu H; Kohrogi H
Nihon Kokyuki Gakkai Zasshi; 2011 Dec; 49(12):897-902. PubMed ID: 22352049
[TBL] [Abstract][Full Text] [Related]
13. [Case of bilateral chylothorax with systemic lupus erythematosus complicated by steroid-/immunosuppressant-resistant pleural effusion].
Narita Y; Naoki K; Hida N; Okamoto H; Kunikane H; Omori T; Kase M; Watanabe K
Nihon Kokyuki Gakkai Zasshi; 2008 Feb; 46(2):120-5. PubMed ID: 18318255
[TBL] [Abstract][Full Text] [Related]
14. Remission of hepatic hydrothorax after OK-432 pleurodesis.
Goto T; Oyamada Y; Hamaguchi R; Shimizu K; Kubota M; Akanabe K; Kato R
Ann Thorac Cardiovasc Surg; 2011; 17(2):208-11. PubMed ID: 21597425
[TBL] [Abstract][Full Text] [Related]
15. A Case of Massive Pleural Effusion: Pleurodesis by Bleomycin.
Hasan R; Khan OS; Aftabuddin M; Razzaque AM; Chowdhury GA
Mymensingh Med J; 2016 Apr; 25(2):374-8. PubMed ID: 27277376
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusion.
Hori T; Mise K; Kan N; Okino T; Satoh K; Yamasaki S; Teramura Y; Harada T; Ohgaki K; Kodama H
Biotherapy; 1992; 5(1):21-9. PubMed ID: 1389900
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
[TBL] [Abstract][Full Text] [Related]
18. [A case of yellow nail syndrome associated with fibrosarcoma of the skin successfully treated with pleurodesis].
Fujita T; Sakurai T; Miki Y; Tomita K; Nakamura T; Toyoda H; Nakamura H
Nihon Kokyuki Gakkai Zasshi; 2010 Mar; 48(3):224-8. PubMed ID: 20387528
[TBL] [Abstract][Full Text] [Related]
19. Malignant pleurisy associated with primary lung cancer well controlled by pleurodesis using distilled water.
Sekiya M; Ishiwata T; Yoshimi K; Nagaoka T; Morio Y; Shiota S; Suzuki T; Seyama K; Takahashi K
Intern Med; 2009; 48(12):1051-5. PubMed ID: 19525597
[TBL] [Abstract][Full Text] [Related]
20. A new fetal therapy for chylothorax: pleurodesis with OK-432.
Okawa T; Takano Y; Fujimori K; Yanagida K; Sato A
Ultrasound Obstet Gynecol; 2001 Oct; 18(4):376-7. PubMed ID: 11778999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
